Loading...
Thumbnail Image
Publication

P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials.

Valgimigli, Marco
Gragnano, Felice
Branca, Mattia
Franzone, Anna
Baber, Usman
Jang, Yangsoo
Kimura, Takeshi
Hahn, Joo-Yong
Zhao, Qiang
Windecker, Stephan
... show 10 more
Alternative Titles
Publisher
Abstract
To assess the risks and benefits of P2Y12 inhibitor monotherapy compared with dual antiplatelet therapy (DAPT) and whether these associations are modified by patients' characteristics.
Language
en
Citation
ISSN
eISSN
1756-1833
ISBN
DOI
10.1136/bmj.n1332
PMID
34135011
PMCID
Sponsorships
Funding Sources
Funding Amounts
Grant Identifiers
Methodology
Duration
Ethical Approval
Embedded videos